Global fight against TB misses 2020 WHO milestones, despite progress in certain age groups

FHS
March 26, 2024
11:11 am

The global, national, and regional burden and trends in tuberculosis.

Psyence Biomed Enters into Agreement to Acquire Stake in PsyLabs | Psychedelic Invest

NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that it has entered into a conditional share sale

September 19, 2024

UTHSC study aims to develop a new way to treat ischemic stroke

A study at the University of Tennessee Health Science Center aims to develop a new way to treat ischemic stroke, a leading cause of death

September 8, 2023

Risk adjusted net present value: What is the current valuation of AstraZeneca’s Saruparib?

Saruparib is a small molecule commercialized by AstraZeneca, with a leading Phase III program in Metastatic Prostate Cancer.

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.